Nikhil Lalwani - 07 Mar 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani
Issuer symbol
ANIP
Transactions as of
07 Mar 2023
Net transactions value
-$604,270
Form type
4
Filing time
09 Mar 2023, 17:44:54 UTC
Previous filing
04 Apr 2023
Next filing
27 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability $415,629 -9,397 -3.3% $44.23 272,560 07 Mar 2023 Direct F1
transaction ANIP Common Stock Tax liability $188,641 -4,265 -1.6% $44.23 268,295 07 Mar 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 25,013 shares of restricted stock, the grant of which was previously reported.
F2 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,338 shares of restricted stock, the grant of which was previously reported.